Rifaximin for preventing episodes of overt hepatic encephalopathy

  • Technology appraisal guidance
  • TA337
  • Published: 
Download (PDF)

What has NICE said?

Rifaximin (Targaxan) is recommended for preventing episodes of hepatic encephalopathy in people aged 18 years or older.

What does this mean for me?

If you have had an episode of hepatic encephalopathy, and your doctor thinks that rifaximin is the right treatment, you should be able to have the treatment on the NHS.

Rifaximin should be available on the NHS within 3 months of the guidance being issued.

  • Information Standard